| Scale up of antiretroviral therapy |
MoPp03 | |
| Type: |
Poster Presentations |
| Venue: |
Poster presentation area |
| Time: |
12:30 - 13:45 |
| Chairpersons: |
Robin Wood, South Africa
Bernhard Schwartländer, Switzerland |
|
Presentations in this session:
12:30
MoPp0301
Abstract
|
Factors associated with ART nonadherence in Dar es Salaam: findings from a cross-sectional study, June - August 2004.
Ndayanga P.O.1, Kwesigabo G.2, Mugusi F.3, Majigo M.2, Almeida A.3, Munubhi E.2
1Interchurch Medical Assistance, Dar Es Salaam, United Republic of Tanzania, 2Muhimbili University College Of Health Sciences, Dar Es Salaam, United Republic of Tanzania, 3Muhimbili National Hospital, Dar Es Salaam, United Republic of Tanzania
|
|
12:35
MoPp0302
Abstract
|
Are the early results reported from community antiretroviral programs in South Africa durable with increasing numbers and time?
Bekker L.-G.1, Orrell C.1, Pitt J.1, Abdullah F.2, Wood R.1
1Desmond Tutu HIV Centre, Cape Town, South Africa, 2Provincial Administration of Western Cape, Cape Town, South Africa
|
|
12:40
MoPp0303
Abstract
|
Estimation of national antiretroviral therapy coverage of medically eligible adults in Cambodia, 1999-2005
Saphonn V.1, Elliott J.1, Heng S.1, Ly P.S.1, Mean C.V.1
1National Center for HIV/AIDS, Dermatology and STDs, Phnom Penh, Cambodia
|
|
12:45
MoPp0304
Abstract
|
Causes of loss to follow up in patients taking antiretroviral therapy in the national rollout program of South Africa.
Ive P.1, Conradie F.1, Xaba S.2, Sanne I.1
1Right To Care, Johannesburg, South Africa, 2CARE, Johannesburg, South Africa
|
|
12:50
MoPp0305
Abstract
|
Response to antiretroviral therapy (ART) in the MTCT-plus initiative, a multi-country HIV care and treatment program in resource-limited countries
Toro P.1, Katyal M.1, Abrams E.1, Austin J.1, Day J.1, El-Sadr W.1, Nash D.1
1Columbia University, New York, United States of America
|
|
12:55
MoPp0306
Abstract
|
Effectiveness of low dose indinavir/ritonavir (IDV/r) at 400mg/100mg twice a day with two nucleoside reverse transcriptase inhibitors (nRTI) as a second-line combination antiretroviral treatment (cART) in non nucleoside reverse transcriptase inhibitors (N
Patel A.1, Patel K.1, Patel J.2, Sharma R.1
1Infectious Diseases Clinic, Ahmedabad, India, 2Adit Diagnostic and Molecular biology centre, Ahmedabad, India
|
|
|